Novartis Ag (NVS) Cash from Investing Activities (2009 - 2025)

Novartis Ag's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$2.1 billion for Q4 2025.

• In Q4 2025, Cash from Investing Activities rose 48.76% year-over-year to -$2.1 billion; the TTM figure through Dec 2025 stood at -$9.3 billion (down 6.56% YoY), while the FY2025 annual figure was -$4.9 billion, up 35.09% from the prior year.
• Cash from Investing Activities came in at -$2.1 billion for Q4 2025 at Novartis Ag, down from -$860.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $5.3 billion in Q4 2021 to a low of -$11.6 billion in Q2 2022.
• A 5-year average of -$1.7 billion and a median of -$1.1 billion in 2021 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities jumped 1019.79% in 2021 and sank 12087.63% in 2022, its largest moves.
• Novartis Ag's Cash from Investing Activities stood at $5.3 billion in 2021, then tumbled by 321.4% to -$11.6 billion in 2022, then soared by 90.94% to -$1.1 billion in 2023, then sank by 289.93% to -$4.1 billion in 2024, then surged by 48.76% to -$2.1 billion in 2025.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$2.1 billion, -$860.0 million, and -$2.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison